Dose-reduced fludarabine, cyclophosphamide and rituximab is well tolerated in older patients with chronic lymphocytic leukemia and has preserved therapeutic efficacy Journal Articles Refereed uri icon

Overview

Published in

  • Leukemia and Lymphoma

Time

Date/time value

  • 2016

Identity

Digital Object Identifier (DOI)

  • 10.3109/10428194.2015.1096353

Additional Document Info

Parent Title

  • LEUKEMIA & LYMPHOMA

Volume

  • 57

Issue

  • 5

Publisher

  • Harwood Academic Publishing GMBH